University of Ferrara
Also known as: Arcispedale S. Anna, Ferrara | Azienda Ospedaliera di Ferrara | Azienda Ospedaliera Sant'Anna | Azienda Ospedaliera Sant'Anna, Ospedale Sant'Anna-Como | Azienda Ospedaliera Universitaria Ferrara | Azienda Ospedaliera Universitria di Ferrara | Azienda USL Ferrara | Clinica Chirurgica, Azienda Ospedaliero-Universitaria Arcispedale S. Anna Ferrara | Ematologia; Azienda Ospedaliera di Ferrara | Marco Valgimigli | Maria Cecilia Hospital | Medical Science Department, University of Ferrara, Italy | Morgagni-Pierantoni Hospital, Forli, Italy | Morgagni-Pierantoni Ospedale | Ospedale Civile di Fidenza | Ospedale Civile di Fidenza, Divisione di Neurologia Via Borghesi 1, 43036 Fidenza (Pr) | Ospedale di Ravenna | Ospedale Pietrantoni, Forli | Ospedale Pietrantoni, Forli, Italy | Ospedale Santa Maria delle Croci | Ospedale Santa Maria Delle Croci, Ravenna, AUSL Romagna | Ospedale Sta. Maria Delle Croci | Regione Emilia-Romagna | Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara | Universita degli Studi di Ferrara | Università degli Studi di Ferrara | Universitaria Arcispedale S. Anna Ferrara | Università degli Studi di Ferrara | University Hospital of Ferrara | University Hospital of Ferrara, Italy | University of Ferrara, Italy | U.O. Clinica Chirurgica, A. O. Univ. Arcispedale S.Anna - Ferrara | UO Oncologia Medica, Ospedale S.Maria delle Croci, RAVENNA - ITALY
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1997Last known activity
Mar 4, 2025
Timeline
1390s
- Jan 1, 1391
University of Ferrara— Founded
Drugs by trial phase (73 distinct, 50 trials)
Phase 4 (31 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Other trials (13 own, 0 via acquisition)
Indications
Studied for
- Abortion, Spontaneous
- Acute Coronary Syndrome
- Asthma
- Atherosclerosis
- beta-Thalassemia
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cardiomyopathies
- Carotid Stenosis
- Coronary Artery Disease
- Coronary Disease
- Heart Diseases
- Hematoma
- Hepatitis, Chronic
- Infarction
- Intestinal Neoplasms
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Macular Degeneration
- Multiple Sclerosis
- Myocardial Infarction
- Myocardial Ischemia
- Ovarian Neoplasms
- Paresis
- Parkinson Disease
- Pulmonary Disease, Chronic Obstructive
- Sclerosis
- Sepsis
- Seroma
- Shoulder Pain
- ST Elevation Myocardial Infarction
- Syndrome
- Takotsubo Cardiomyopathy
- Thalassemia
- Toxemia
Recent trials (50)
- NCT06872151CollaboratorPhase 4Mar 4, 2025
- NCT06815679OfficialPhase 2/Phase 3Mar 1, 2025
- NCT06815679Sponsor investigatorPhase 2/Phase 3Mar 1, 2025
- NCT06815679Lead sponsorPhase 2/Phase 3Mar 1, 2025
- NCT06685120CollaboratorN/AJan 31, 2025
- NCT06482294Sponsor investigatorPhase 2Jun 18, 2024
- NCT06482294Lead sponsorPhase 2Jun 18, 2024
- NCT06482294OfficialPhase 2Jun 18, 2024
- NCT06432309Lead sponsorN/AOct 1, 2022
- NCT04979468Overall official - principal investigatorPhase 3Mar 23, 2021
- NCT05136625Study chairN/AFeb 1, 2021
- NCT05136625Lead sponsorN/AFeb 1, 2021
- NCT04247750Lead sponsorPhase 2Feb 28, 2020
- NCT03877809CollaboratorPhase 2Jun 27, 2019
- NCT03806816Reponsible party - principal investigatorN/ADec 13, 2018
Details
- Founded
- Ferrara, IT Jan 1, 1391
- Last known activity
- Mar 4, 2025